tiprankstipranks
Metagenomi, Inc. (MGX)
NASDAQ:MGX
US Market

Metagenomi, Inc. (MGX) Income Statement

Compare
878 Followers

Metagenomi, Inc. Income Statement

Last quarter (Q3 2024), Metagenomi, Inc.'s total revenue was $11.51M, a decrease of -6.87% from the same quarter last year. In Q3, Metagenomi, Inc.'s net income was $-18.77M. See Metagenomi, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 44.76M$ 17.20M$ 243.00K
Gross Profit
$ -49.65M$ 15.47M$ -144.00K
Operating Expenses
$ 123.25M$ 61.84M$ 24.19M
Depreciation and Amortization
$ 4.21M$ 1.73M$ 387.00K
EBITDA
$ -56.02M$ -39.19M$ -20.75M
Operating Income
$ -78.49M$ -44.64M$ -23.95M
Other Income/Expenses
$ 18.26M$ 3.62M$ 2.50M
Pretax Income
$ -60.23M$ -41.02M$ -21.44M
Net Income
$ -68.25M$ -43.59M$ -21.44M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ -1.82$ -1.45$ -0.72
Diluted EPS
$ -1.82$ -1.45$ -0.72
Weighted Average Shares Outstanding
37.53M 29.96M 29.96M
Weighted Average Shares Outstanding (Diluted)
37.53M 29.96M 29.96M
Currency in USD

Metagenomi, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis